April 21 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO is seeking to name Perrigo Co (NYSE:PRGO) Plc's PRGO.N Joseph
Papa as its new chief executive, CNBC tweeted, citing Dow Jones.
Valeant is finalizing a contract with the Perrigo CEO and an
announcement of his appointment could come as soon as next week,
a CNBC tweet said.
Valeant and Perrigo could not be reached immediately for
comment outside regular business hours.